Cipla invests in a respiratory device firm

The company said that it will acquire 60 percent stake in Jay Precision Pharmaceuticals

id-100170733

Jay Precision currently supplies respiratory devices to Cipla

Cipla has announced that it will acquire 60 percent stake in Jay Precision Pharmaceuticals for Rs 96 crore, says reports.

Jay Precision is an existing supplier of respiratory devices to the company and has a manufacturing facility at Vasai, Maharashtra.

"Considering company's leading position in inhalation therapy, this transaction is aimed at integrating the value chain and will serve as a platform for the development of next generation respiratory devices," the company said in a statement.

The transaction is expected to be completed by the end of this financial year, subject to completion of certain conditions.

 

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X